Top Ranked Momentum Stocks to Buy for April 21st
“We are pleased to have successfully completed the DalcA Phase 2b trial during this challenging pandemic and remain on track to report final results later this quarter,” said Nassim Usman, Ph.D.,
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eagle Pharmaceuticals (EGRX) and Actinium Pharmaceuticals
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eagle Pharmaceuticals
Dublin, April 17, 2020 -- The "Impact of COVID-19 on Global Digital PCR Industry" report has been added to ResearchAndMarkets.com's offering. Global Digital.
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB) and Vascular Biogenics (VBLT) with bullish
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB
The "Impact of COVID-19 on Global Digital PCR Industry" report has been added to ResearchAndMarkets.com's offering.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) * Bio-Rad Laboratories, Inc. Class B Common Stock
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company (STAA), Planet 13 Holdings (PLNHF)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company ( STAA – Research Report ), Planet 13 Holdings ( PLNHF – Research Report ) a

Oppenheimer Remains a Buy on Athenex (ATNX)

01:39pm, Thursday, 09'th Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX), with a price target of $23.00. The company's shares

Oppenheimer Remains a Buy on Athenex (ATNX)

01:39pm, Thursday, 09'th Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX – Research Report), with

Novavax (NVAX) Received its Third Buy in a Row

01:29pm, Wednesday, 08'th Apr 2020
After Ladenburg Thalmann & Co. and Cantor Fitzgerald gave Novavax (NASDAQ: NVAX) a Buy rating last month, the company received another Buy, this time

Novavax (NVAX) Received its Third Buy in a Row

01:29pm, Wednesday, 08'th Apr 2020
After Ladenburg Thalmann & Co. and Cantor Fitzgerald gave Novavax (NASDAQ: NVAX) a Buy rating last month, the company received
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE